ADRC News

On January 6, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.

Sanjay Asthana, MD, professor, and Duncan G. and Lottie H. Ballantine Chair, Geriatrics and Gerontology, has been invited by the US Secretary of Health and Human Services and the Director of the National Institutes of Health (NIH) to serve a four-year appointment on the National Advisory Council on Aging.

In 2022, 'Dementia Matters' released 31 episodes about Alzheimer's disease research advances, caregiver strategies and prevention tips from local and national dementia experts. Listed here are the five most popular 'Dementia Matters' episodes of 2022.

Ozioma Okonkwo, PhD, has been appointed to participate in a National Institute on Aging Alzheimer’s (NIA) and Alzheimer’s Association workgroup, establishing the definition and classification of Alzheimer’s disease.

Indigenous people living in Wisconsin and throughout the nation experience significant health and financial burden from Alzheimer’s disease and related dementias, according to new research published by a University of Wisconsin–Madison team and collaborators.

Sterling Johnson, PhD, has been awarded a Vilas Distinguished Achievement Professorship, an appointment given to extraordinary members of the University of Wisconsin–Madison faculty.

This free community educational event offered news about cutting-edge research in Alzheimer's disease and provided information to help people improve brain health and live healthier lives.

The 'Dementia Matters' podcast turned five this month, marking nearly 150 episodes connecting scientists from UW–Madison and the national and international science community with thousands of listeners worldwide. The podcast is among the most highly-downloaded podcasts available, with listener numbers ranking it in the top twenty percent of all podcasts.

Fabu Carter, PhD, was recently presented with the 2022 Champion of Hope Award by NewBridge Madison.

Cynthia Carlsson, MD, MS, and Nathaniel Chin, MD, weigh in on the experimental drug lecanemab and share more about the AHEAD study happening at UW–Madison, one of 100 research sites in the world currently offering a clinical study of lecanemab.